Table 1.

Demographic and clinical information of the analysed PDAC samples.

PDAC case number	Gender	Age	Grade	pT	pN	pM	Analysis
13	F	73	G2	T3	N1	M0	EA
14	M	64	G2	T3	N1	M0	EA
16	F	50	G2	T3	N1	M0	EA/qPCR
17	F	59	G3	T3	N1	M0	EA/qPCR
19	M	62	G2	T3	N1	M0	EA/qPCR
20*	M	63	G3	T3	N1	M0	EA
21	F	77	G2	T3	N1	M0	EA
22	M	80	G2	T3	N1	M0	EA/qPCR
23	M	73	G2	T3	N1	M0	EA/qPCR
24	F	59	G3	T3	N1	M0	EA/qPCR
25	F	71	G2	T3	N1	M0	EA
27	F	42	G2	T2	N1	M0	EA/qPCR
32	M	67	G2	T3	N1	M0	EA/qPCR
35	F	68	G2	T4	N0	M0	EA
46	M	68	G2	T1	N0	M1	EA/qPCR
54	F	41	G3	T2	N0	M0	EA/qPCR
55	M	55	G2	T3	N1	M0	EA
60	F	65	G3	T3	N1	M0	EA/qPCR
63	M	67	G3	T4	N1	M0	EA/qPCR
64	M	59	G3	T3	N1	M0	EA
80	M	74	G2	T3	N1	M0	EA
100	F	73	G2	T3	N0	M0	EA/qPCR
102	F	73	G2	T3	N1	M0	EA
108	M	59	G3	T4	N1	M0	EA
150	M	53	G3	T3	N1	M0	EA
163	M	64	G2	T3	N1	M0	EA
169	M	66	G2	T4	N1	M0	EA
173	M	60	G3	T3	N1	M0	EA
89	M	81	G2	T4	N1	M0	qPCR
71	F	67	G3	T3	N1	M0	qPCR
73	F	74	G2	T3	N1	M0	qPCR
75	F	32	G2	T3	N0	M0	qPCR
95	M	68	G3	T3	N1	M0	qPCR
152	M	62	G3	T3	N0	M0	qPCR
166	F	65	G2	T3	N1	M0	qPCR
11	F	59	G3	T3	N1	M0	qPCR
15	F	67	G3	T3	N1	M0	qPCR

^*This sample was derived from the patient that received neoadjuvant therapy (Gemcitabine + Oxaliplatin; all the remaining samples were obtained from naive patients. EA = exon array; qPCR = quantitative polymerase chain reaction; pTNM (pathology staging: Tumour, lymph Nodes, Metastasis).